NCT02607748View on ClinicalTrials.gov

18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 13, 2015

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Coronary Artery DiseaseAtherosclerotic Plaque
Interventions
OTHER

18F-NaF PET and coronary CTA imaging

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT02607748 - 18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques | Biotech Hunter | Biotech Hunter